Organization
Department of Thoracic Surgery, Peking Union Medical College Hospital,CAMS & PUMC
1 abstract
Abstract
Neoadjuvant tislelizumab plus chemotherapy for resectable locally advanced esophageal squamous cell carcinoma (ESCC): Interim analysis of a phase 2 study.Org: Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) “Dino Amadori”, Meldola, Italy, Italy, Department of Thoracic Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, China, Department of Thoracic Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, China, Guangzhou, China, Geneseeq Research Institute, Nanjing Geneseeq Technology Inc., Nanjing, China, Nanfang Hospital, Southern Medical University, Guangzhou, China, Department of Thoracic Surgery, Peking Union Medical College Hospital,CAMS & PUMC, Department of Gastroenterology and Urology, Department of Pathology, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy,